Bioventus Inc. Class A Common Stock (BVS) Stock Price

BVSStock

$13.84+90.90%52W

Market Cap$945.34M

P/E51.38x

PEG Ratio1.76

Div yield—

Beta0.68

BVS Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)46.79%

Price vs S&P 500 (4W)1.21%

PEG Ratio1.76

VGM Score63.54

P/E Ratio (Annual)51.38x

P/CF (Annual)15.64x

Book Value / Share (Quarterly)$2.26

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)3.52%

Cash Flow / Share (Quarterly)$1.21

Price vs S&P 500 (YTD)73.20%

Gross Margin (TTM)68.69%

Net Profit Margin (TTM)4.94%

EPS (TTM)$0.41

10-Day Avg Trading Volume0.58M

EPS Excl Extra (TTM)$0.41

Revenue Growth (5Y)12.08%

EPS (Annual)$0.33

ROI (Annual)4.66%

Gross Margin (Annual)68.33%

Net Profit Margin (5Y Avg)-11.86%

Cash / Share (Quarterly)$0.43

P/E Basic Excl Extra (TTM)41.01x

Revenue Growth QoQ (YoY)6.63%

EPS Growth (5Y)2.26%

P/E Normalized (Annual)51.38x

ROA (Last FY)3.33%

Revenue Growth TTM (YoY)1.52%

EBITD / Share (TTM)$0.90

ROE (5Y Avg)-29.59%

Operating Margin (TTM)9.92%

Cash Flow / Share (Annual)$0.87

P/B Ratio6.18x

P/B Ratio (Quarterly)3.94x

Net Income / Employee (Annual)$24,400

EV / Revenue (TTM)2.45x

Net Interest Coverage (TTM)2.02x

ROA (TTM)4.15%

EV / EBITDA (TTM)22.64x

EPS Incl Extra (Annual)$0.33

Current Ratio (Annual)1.70x

Quick Ratio (Quarterly)1.06x

3-Month Avg Trading Volume0.68M

52-Week Price Return90.90%

EV / Free Cash Flow (Annual)19.60x

P/E Incl Extra (TTM)41.01x

Revenue / Employee (TTM)$619,700

Tangible BV / Share (Quarterly)$-4.10

P/S Ratio (Annual)2.06x

Asset Turnover (Annual)0.83x

52-Week High$15.89

Operating Margin (5Y Avg)-11.17%

EPS Excl Extra (Annual)$0.33

CapEx CAGR (5Y)-8.93%

26-Week Price Return58.72%

Quick Ratio (Annual)1.12x

13-Week Price Return56.03%

Total Debt / Equity (Annual)1.65x

Current Ratio (Quarterly)1.69x

Enterprise Value$1.41B

Revenue / Share Growth (5Y)7.37%

Asset Turnover (TTM)0.84x

Revenue / Employee (Annual)$610,800

Inventory Turnover (Annual)2.06x

Pretax Margin (Annual)4.53%

Cash / Share (Annual)$0.62

3-Month Return Std Dev59.86%

Gross Margin (5Y Avg)67.00%

Net Income / Employee (TTM)$30,600

EBITDA CAGR (5Y)12.60%

EBITDA Interim CAGR (5Y)-16.81%

ROE (Last FY)12.35%

Net Interest Coverage (Annual)2.53x

EPS Basic Excl Extra (Annual)$0.33

P/FCF (TTM)11.61x

Receivables Turnover (TTM)4.83x

EV / Free Cash Flow (TTM)14.05x

Total Debt / Equity (Quarterly)1.49x

EPS Incl Extra (TTM)$0.41

Receivables Turnover (Annual)4.44x

ROI (TTM)5.79%

P/S Ratio (TTM)2.03x

Pretax Margin (5Y Avg)-15.60%

Revenue / Share (Annual)$8.24

Tangible BV / Share (Annual)$-9.45

Forward P/E15.64x

Free OCF CAGR (5Y)1.27%

Price vs S&P 500 (52W)72.34%

P/E Ratio (TTM)41.01x

Year-to-Date Return86.02%

5-Day Price Return-1.28%

EPS Normalized (Annual)$0.33

ROA (5Y Avg)-6.18%

Net Profit Margin (Annual)4.00%

Month-to-Date Return5.09%

Cash Flow / Share (TTM)$-1.35

EBITD / Share (Annual)$0.86

Operating Margin (Annual)9.44%

LT Debt / Equity (Annual)1.52x

P/CF (TTM)11.35x

ROI (5Y Avg)-9.77%

P/E Excl Extra (TTM)41.01x

LT Debt / Equity (Quarterly)1.34x

EPS Basic Excl Extra (TTM)$0.41

P/B Ratio (Annual)3.34x

Inventory Turnover (TTM)2.04x

Pretax Margin (TTM)5.84%

Book Value / Share (Annual)$2.22

Price vs S&P 500 (13W)54.08%

Net Margin Growth (5Y)-4.78%

Beta0.68x

P/FCF (Annual)16.20x

Revenue / Share (TTM)$8.23

ROE (TTM)16.27%

52-Week Low$6.25

vGradeB

gGradeC

mGradeA

vgmGradeB

BVS Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 5, 2026	$0.22	$0.22	+0.92%(+$0.00)
Q1 2026	May 6, 2026	$0.07	$0.15	+120.59%(+$0.08)
Q4 2025	Mar 5, 2026	$0.22	$0.24	+10.77%(+$0.02)
Q3 2025	Nov 4, 2025	$0.12	$0.15	+30.43%(+$0.03)
Q2 2025	Aug 6, 2025	$0.20	$0.21	+6.78%(+$0.01)

BVS Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.11

Industry Peers — Surgical & Medical Instruments(140)

Symbol	Value Score	Growth Score	Momentum Score	Price
BVSBioventus Inc. Class A Common Stock	B	C	A	$13.84
SYKStryker Corporation	C	B	C	$330.69
MMM3M Company	C	D	C	$174.34
BSXBoston Scientific Corp.	C	B	D	$46.84
BDXBecton, Dickinson and Co.	B	D	B	$189.52
MDLNMedline Inc. Class A common stock	C	D	C	$35.28
RMDResMed Inc.	C	B	B	$240.33
DXCMDexCom, Inc.	D	B	B	$90.82
WSTWest Pharmaceutical Services, Inc.	D	C	B	$337.47
SOLVSolventum Corporation	C	C	B	$91.12
BAXBaxter International Inc.	B	D	B	$26.13
PENPenumbra, Inc.	D	C	C	$321.68
GMEDGLOBUS MEDICAL INC	B	B	C	$82.97
GKOSGlaukos Corporation	F	A	A	$179.87
PODDInsulet Corporation	C	A	C	$145.13
TFXTeleflex Incorporated	B	F	B	$139.67
STVNStevanato Group S.p.A.	D	C	C	$21.03
MMEDMiniMed Group, Inc. Common Stock	—	—	A	$20.10
MMSIMerit Medical Systems Inc	C	B	B	$90.49
HAEHaemonetics Corporation	C	C	A	$103.96
ICUIICU Medical Inc	C	D	B	$175.10
HTFLHeartflow, Inc. Common Stock	—	A	B	$47.78
IRTCiRhythm Holdings, Inc. Common Stock	F	A	C	$120.25
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	$47.57
ATRCAtriCure, Inc.	D	B	B	$48.54
UFPTUFP Technologies Inc	C	B	B	$300.05
NVCRNovoCure Limited Ordinary Shares	D	C	B	$17.82
LMATLeMaitre Vascular, Inc.	C	B	C	$80.45
INSPInspire Medical Systems, Inc.	B	B	B	$61.44
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	$25.64
TNDMTandem Diabetes Care, Inc.	D	C	B	$21.43
ATECAlphatec Holdings, Inc.	D	B	C	$9.44
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	A	$14.64
IARTIntegra LifeSciences Holdings	B	D	B	$16.89
AORTArtivion, Inc.	C	C	C	$26.77
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	$20.83
IRMDiRadimed Corporation	D	B	C	$87.07
BBNXBeta Bionics, Inc. Common Stock	D	A	B	$19.72
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	$26.42
SIBNSI-BONE, Inc. Common Stock	D	B	B	$19.21
SSIISS Innovations International Inc. Common Stock	F	A	D	$3.48
MDXGMiMedx Group, Inc	C	D	C	$4.50
ANGOAngioDynamics, Inc.	C	D	A	$15.85
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	$23.65
BWAYBrainsway Ltd. American Depositary Shares	F	A	B	$14.30
DCTHDelcath Systems Inc	D	B	A	$16.34
CERSCerus Corp	D	C	B	$2.65
TCMDTactile Systems Technology, Inc.	B	B	C	$23.16
NPCENeuropace, Inc. Common Stock	D	C	B	$14.41
CLPTClearPoint Neuro, Inc. Common Stock	F	A	B	$15.55
SGHTSight Sciences, Inc. Common Stock	D	B	A	$8.55

About Bioventus Inc. Class A Common Stock

Bioventus Inc. is a medical technology company that develops clinically differentiated treatments enhancing natural healing processes across the orthopedic continuum. Its product portfolio serves multiple orthopedic specialties—including sports medicine, joint reconstruction, trauma, and spine surgery—organized into three verticals: Pain Treatments, Surgical Solutions, and Restorative Therapies. The company generates key revenue in the United States with growing international market presence.